These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9669246)

  • 1. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction.
    Anderson JL; Carlquist JF; Muhlestein JB; Horne BD; Elmer SP
    J Am Coll Cardiol; 1998 Jul; 32(1):35-41. PubMed ID: 9669246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease.
    Muhlestein JB; Horne BD; Carlquist JF; Madsen TE; Bair TL; Pearson RR; Anderson JL
    Circulation; 2000 Oct; 102(16):1917-23. PubMed ID: 11034939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker.
    Jha HC; Prasad J; Mittal A
    Heart Vessels; 2008 Nov; 23(6):390-6. PubMed ID: 19037586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death.
    Zhu J; Quyyumi AA; Muhlestein JB; Nieto FJ; Horne BD; Zalles-Ganley A; Anderson JL; Epstein SE
    Am J Cardiol; 2002 Jan; 89(2):155-8. PubMed ID: 11792334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of pathogen burden and risk of myocardial infarction or death.
    Zhu J; Nieto FJ; Horne BD; Anderson JL; Muhlestein JB; Epstein SE
    Circulation; 2001 Jan; 103(1):45-51. PubMed ID: 11136684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
    Al-Ghamdi A; Jiman-Fatani AA; El-Banna H
    Pak J Pharm Sci; 2011 Apr; 24(2):95-101. PubMed ID: 21454155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: role of confounding and reference group.
    Rothenbacher D; Brenner H; Hoffmeister A; Mertens T; Persson K; Koenig W
    Atherosclerosis; 2003 Oct; 170(2):339-45. PubMed ID: 14612216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age.
    Gattone M; Iacoviello L; Colombo M; Castelnuovo AD; Soffiantino F; Gramoni A; Picco D; Benedetta M; Giannuzzi P
    Am Heart J; 2001 Oct; 142(4):633-40. PubMed ID: 11579353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious risk factors for atherosclerotic vascular disease in hemodialysis patients--Chlamydia pneumoniae but not Helicobacter pylori or cytomegalovirus is associated with increased C-reactive protein.
    Wolf SC; Brehm BR; Mayer O; Jürgens S; Schultze G; Risler T
    Ren Fail; 2004 May; 26(3):279-87. PubMed ID: 15354978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the correlation of between infection, inflammation and coronary artery disease].
    Cai XJ; Cai HB; Lu D
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jun; 24(6):503-7. PubMed ID: 12848920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An elevated value of C-reactive protein is the only predictive factor of restenosis after percutaneous coronary intervention.
    Jeong WK; Jeong MH; Kim KH; Lee SR; Park OY; Yum JH; Kim JH; Kim W; Rhew JY; Ahn YK; Cho JG; Ahn BH; Suh SP; Park JC; Kim SH; Kang JC
    Korean J Intern Med; 2003 Sep; 18(3):154-60. PubMed ID: 14619384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction.
    Witherell HL; Smith KL; Friedman GD; Ley C; Thom DH; Orentreich N; Vogelman JH; Parsonnet J
    Ann Epidemiol; 2003 Mar; 13(3):170-7. PubMed ID: 12604160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
    Cavusoglu Y; Gorenek B; Alpsoy S; Unalir A; Ata N; Timuralp B
    Isr Med Assoc J; 2001 Jan; 3(1):13-6. PubMed ID: 11344793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease.
    Rupprecht HJ; Blankenberg S; Bickel C; Rippin G; Hafner G; Prellwitz W; Schlumberger W; Meyer J;
    Circulation; 2001 Jul; 104(1):25-31. PubMed ID: 11435333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis.
    Mayr M; Kiechl S; Willeit J; Wick G; Xu Q
    Circulation; 2000 Aug; 102(8):833-9. PubMed ID: 10952949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parameters of inflammation and infection in a community based case-control study of coronary heart disease.
    De Backer J; Mak R; De Bacquer D; Van Renterghem L; Verbraekel E; Kornitzer M; De Backer G
    Atherosclerosis; 2002 Feb; 160(2):457-63. PubMed ID: 11849671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of common chronic infections with coronary artery disease in patients without any conventional risk factors.
    Goyal P; Kalek SC; Chaudhry R; Chauhan S; Shah N
    Indian J Med Res; 2007 Feb; 125(2):129-36. PubMed ID: 17431281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction.
    Choussat R; Montalescot G; Collet J; Jardel C; Ankri A; Fillet A; Thomas D; Raymond J; Bastard J; Drobinski G; Orfila J; Agut H; Thomas D
    Am J Cardiol; 2000 Aug; 86(4):379-84. PubMed ID: 10946028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease.
    Schumacher A; Seljeflot I; Lerkerød AB; Sommervoll L; Otterstad JE; Arnesen H
    Atherosclerosis; 2002 Sep; 164(1):153-60. PubMed ID: 12119204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention.
    Horne BD; Muhlestein JB; Strobel GG; Carlquist JF; Bair TL; Anderson JL;
    Am Heart J; 2002 Sep; 144(3):491-500. PubMed ID: 12228787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.